Teachers Advisors LLC decreased its position in shares of Medtronic plc. (NYSE:MDT) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,278,097 shares of the medical technology company’s stock after selling 18,175 shares during the period. Teachers Advisors LLC owned about 0.17% of Medtronic worth $183,956,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Janus Henderson Group PLC acquired a new position in shares of Medtronic in the 3rd quarter valued at about $579,952,000. BlackRock Inc. lifted its position in Medtronic by 6.4% in the 4th quarter. BlackRock Inc. now owns 94,595,580 shares of the medical technology company’s stock valued at $7,638,592,000 after purchasing an additional 5,688,180 shares during the last quarter. American Century Companies Inc. lifted its position in Medtronic by 35.0% in the 3rd quarter. American Century Companies Inc. now owns 9,082,452 shares of the medical technology company’s stock valued at $706,342,000 after purchasing an additional 2,354,467 shares during the last quarter. Asset Management One Co. Ltd. lifted its position in Medtronic by 3,863.2% in the 3rd quarter. Asset Management One Co. Ltd. now owns 2,064,912 shares of the medical technology company’s stock valued at $160,588,000 after purchasing an additional 2,012,810 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its position in Medtronic by 20.7% in the 3rd quarter. Ameriprise Financial Inc. now owns 11,388,438 shares of the medical technology company’s stock valued at $885,673,000 after purchasing an additional 1,954,535 shares during the last quarter. 80.79% of the stock is currently owned by hedge funds and other institutional investors.
In related news, EVP Bryan C. Hanson sold 16,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $82.82, for a total transaction of $1,325,120.00. Following the transaction, the executive vice president now directly owns 88,818 shares of the company’s stock, valued at $7,355,906.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Richard Kuntz sold 78,526 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $86.21, for a total transaction of $6,769,726.46. Following the transaction, the vice president now directly owns 149,761 shares in the company, valued at $12,910,895.81. The disclosure for this sale can be found here. Over the last three months, insiders sold 145,163 shares of company stock worth $12,232,045. 0.31% of the stock is currently owned by insiders.
Medtronic plc. (NYSE:MDT) opened at $83.15 on Monday. The firm has a market cap of $112,699.27, a P/E ratio of 40.96, a PEG ratio of 2.36 and a beta of 0.97. The company has a quick ratio of 2.09, a current ratio of 2.43 and a debt-to-equity ratio of 0.51. Medtronic plc. has a 1 year low of $76.51 and a 1 year high of $89.72.
Medtronic (NYSE:MDT) last released its earnings results on Tuesday, February 20th. The medical technology company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.01. The business had revenue of $7.37 billion for the quarter, compared to the consensus estimate of $7.20 billion. Medtronic had a net margin of 9.44% and a return on equity of 12.65%. The firm’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same period last year, the firm posted $1.12 earnings per share. research analysts predict that Medtronic plc. will post 4.75 EPS for the current year.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.